Symkevi
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Symkevi, covering 2025-12-08 to 2025-12-08. Get the full timeline:
Most recent: EMA Authorised: Symkevi (tezacaftor;ivacaftor) — Vertex Pharmaceuticals (Ireland) Limited